Pregnancy & Labour Flashcards
Screening tests play a key role in antenatal care. Define sensitivity and specificity, in relation to these tests.
Sensitivity = [true +] / [+ve + false -ve]. Identifies those with a disease Specificity = [true -] / [-ve + false +ve]. Identifies those without a disease.
Describe the key investigations undertaken at the antenatal booking visit [5].
- histories: O&G, medical, surgical, allergies, psychiatric, family and social health
- physical health: height, weight, BP
- blood tests: Hb, ABO, Rh status, infection screen (syphilis, HIV, HBV, HCV)
- urinalysis (e.g., DM)
- ultrasound: estimates gestational age, detects major structural anomalies
At what time is the antenatal booking visit normally undertaken?
8-12 weeks gestation
Describe how gestational age is estimated until ultrasound is performed at the booking visit.
Naegele’s rule: LMP (last menstrual period) + 9 months and 7 days (280 days)
What is placenta previa?
The placenta encroaches on the cervix at the anomaly scan; it does not move at the repeat scan 2 weeks later and requires Caeseran section
Name and describe the three screenable trisomies in pregnancy, and describe how screening for these changes as first presentation changes with gestational age.
- trisomy 13 [Patau syndrome]; trisomy 18 [Edward syndrome]: both generally lethal, mosaics assc. with severe physical and mental disability
- trisomy 21: varies widely from mild to profound disability (structural defects in heart, duodenum, thyroid; increased rates of cancer, learning disability)
- all three may be screened for in the first trimester. only Down syndrome may be screened for in the second trimester
Describe the non-invasive methods for genetic screening.
- nuchal thickness (on USS): increased thickness at the back of the foetal neck
- NIPT (non-invasive prenatal testing): assesses placental (foetal) DNA in maternal serum; >90% accuracy, although results affected by maternal BMI
Describe the key differences in amniocentesis and chorionic villous sampling.
- amniocentesis: >15 weeks, risk of miscarriage <1%
- CVS: >12 weeks, risk of miscarriage 2%
Describe how rhesus sensitisation works [4].
- Rh +ve father and Rh -ve mother produces a Rh +ve foetus
- Rh +ve foetus blood exchanged into maternal circulation
- this causes production of maternal antibodies, which remain lifelong
- second pregnancy with Rh +ve foetus will cause maternal antibodies to cross and attack foetus
What are the risks of rhesus sensitisation in mother and foetus of opposite status?
May cause foetal hydrops and death
Describe how rhesus problems are treated, both during pregnancy and in other O&G situations.
- early delivery; blood or intrauterine transfusion
- anti-D injections to prevent antigens forming in Rh -ve women given at 28w and after any sensitising event (TOP, APH, trauma etc.)
- after birth, cord blood is tested and anti-D is given if the baby is Rh +ve
Define ‘small for gestational age’ and ‘foetal growth restriction’.
- SGA: birth weight <10th centile.
- abdominal circumference (AC) / estimated foetal weight (EFW) <3rd centile
- AC / EFW <10th centile, plus evidence of placental dysfunction
- FGR: failure to achieve genetic potential for growth, implying pathological restriction of genetic growth potential
Describe the main causes of a SGA foetus [3].
- placental: infarct, abruption, hypertension
- foetal: infection (particularly rubella, CMV), congenital (e.g., absent kidneys), chromosomal abnormalities
- maternal: lifestyle, BMI, age, disease
Describe the increased risks to the foetus and mother with an SGA foetus [3].
- stillbirth
- morbidity, GDM, PET
- mortality: hypoxia, hypoglycaemia, chronic asphyxia, hypothermia, polycythaemia, hyperbilirubinaemia, abnormal neurodevelopment
Describe how foetal size is screened during pregnancy [4].
- SFH (symphysis-fundal height)
- performed from 24 weeks and plotted on a graph
- single SFH <10th centile / serial measurement crossing centile lines should be referred for USS
- SFH inaccuracies (BMI > 35, large fibroids, hydramnios) require USS use.
Describe the risk factors for an SGA foetus [8].
[first quantifier indicates minor factor, second indicates major]
- age (>35, >40)
- nulliparity, IVF
- pregnancy interval <6 or >60 months
- BMI (<20/25-35, >35)
- smoking (<10/day, >11/day)
- previous SGA, parental SGA [major]
- non-O&G conditions: chronic HTN, DM w/ vascular disease, renal impairment, APLS
- O&G conditions: previous PET, heavy bleeds, large fibroids, uterine artery notching at 20wks
Describe the management of an SGA foetus [4].
- aspirin 150mg for 12 weeks, steroids from 24-35+6wk, magnesium sulfate <32 wk
- genetic tests, infection screen, serial scans for growth, measurement of liquour volume, umbilical artery Doppler
- <3rd centile: delivery from 37 - 37+6 wk
- 3rd-10th centile: delivery at 39w
Define LGA.
SFH >2cm for gestational age (e.g., 28cm at 24w is +4cm)
What are the main causes of LGA? [5]
- foetal macrosomia
- polyhydramnios
- multiple pregnancy
- pre-existing diabetes
- GDM
Define foetal macrosomia, describe associated risks and management.
- EFW >90th centile, AC >97th centile
- risks: anxiety, shoulder and labour dystocia, PPH
- Mx: exclude DM, reassure, offer options (conservative, IOL, C/S; latter is only option when weight >5kg)
Regarding polyhydramnios, describe the:
- definition
- causes
- symptoms
- investigations
- excess amniotic fluid within the uterus; may be quantified as AFI >25cm or a deepest pool >8cm
- maternal (DM), foetal (anomlies, monochorionic twin pregnancy, hydrops, viral infection)
- abdominal discomfort, pre-labour rupture of membranes, preterm labour, cord-prolapse,, malpresentation, tense shiny abdomen
- OGTT, viral serology (parvovirus B19, toxo, CMV), serial USS survey
Multiple pregnancy develops differently depending on at which stage the egg splits; describe the timeline [3].
- morula: forms DC/DA. Lambda sign on USS
- blastocyst: forms MC/DA. T sign on USS
- implanted blastocyst: forms MC/MA
[MC = monochorionic, DC = dichorionic, MA = monoamniotic, DA = diamniotic]
Two risks of multiple pregnancy are single foetal death and selective growth restriction. Describe how these are managed.
- single foetal death: MRI on surviving foetal brain 4 weeks after IUD. perform MCA PSV for foetal anaemia
- selective growth restriction: selective reduction (early onset + abnormal Doppler)
Describe TTTS (twin-to-twin transfusion syndrome) and its main complication, TAPS (twin anaemia polycythaemia sequence). [3]
- TTTS: donor twin perfuses recipient via artery-vein anastomoses
- treatment is via foetoscopic laser ablation
- TAPS is a complication of laser ablation. MCA PSV is used to monitor for anaemia